High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.6M
$3,552,671
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -13.9%
2026-03-04
$1,158,306Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -13.9%
|
2026-03-04 | $1,158,306Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -11.1%
2026-02-25
$1,215,875Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -11.1%
|
2026-02-25 | $1,215,875Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -12.1%
2026-02-25
$1,178,490Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -12.1%
|
2026-02-25 | $1,178,490Large | S | Form 4 |